Arcus Biosciences (RCUS) Net Margin (2017 - 2026)
Arcus Biosciences (RCUS) posted Net Margin of -221.95% for Q2 2026, up 530.99 percentage points from the prior quarter.
Arcus Biosciences (RCUS) Net Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Arcus Biosciences was -393.16%, down 279.42 percentage points year-over-year; for FY2025, it was -142.91%, down 33.23 percentage points from FY2024.
- Annual Net Margin shows a five-year change of +14.78 percentage points (FY2020 to FY2025).
- In prior years, Arcus Biosciences' Net Margin was -109.69% in FY2024 (+152.70 pp), -262.39% in FY2023 (-24.00 pp), -238.39% in FY2022 (-252.23 pp) and 13.84% in FY2021 (+171.53 pp).
- The Q2 2026 figure stands as the highest quarterly Net Margin since Q3 2024.
- On a year-over-year basis, Net Margin increased in two of the last six quarters, with an average year-over-year change of -184.58 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q3 2022, with a gain of 627.20 percentage points; the weakest was Q3 2021, with a drop of 827.00 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -752.94% (Q1 2026), -321.21% (Q4 2025) and -519.23% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | -221.95% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -221.95% |
| Mar 31, 2026 | -752.94% |
| Dec 31, 2025 | -321.21% |
| Sep 30, 2025 | -519.23% |
| Mar 31, 2025 | -400.00% |
| Dec 31, 2024 | -361.54% |
| Sep 30, 2024 | -191.67% |
| Jun 30, 2024 | -238.46% |
| Mar 31, 2024 | -2.76% |
| Dec 31, 2023 | -261.29% |
| Sep 30, 2023 | -221.88% |
| Jun 30, 2023 | -258.62% |
| Mar 31, 2023 | -320.00% |
| Dec 31, 2022 | -197.06% |
| Sep 30, 2022 | -196.97% |
| Jun 30, 2022 | -248.15% |
| Mar 31, 2022 | -377.78% |
| Dec 31, 2021 | 78.83% |
| Sep 30, 2021 | -824.17% |
| Jun 30, 2021 | -802.98% |
Arcus Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();